{
    "Trade/Device Name(s)": [
        "Elecsys\u00ae PreciControl Universal",
        "PreciControl Universal"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K051687",
    "Predicate Device Reference 510(k) Number(s)": [
        "K033937"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "JJY"
    ],
    "Summary Letter Date": "July 25, 2005",
    "Summary Letter Received Date": "June 24, 2005",
    "Submission Date": "June 22, 2005",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine",
        "immunology"
    ],
    "Analyte(s)": [
        "AFP",
        "Cortisol",
        "DHEAs",
        "Estradiol",
        "Ferritin",
        "Folate",
        "FSH",
        "L-Thyroxin",
        "hCG",
        "IgE",
        "Insulin",
        "LH",
        "Progesterone",
        "Prolactin",
        "Testosterone",
        "SHBG",
        "T3",
        "TSH",
        "Vitamin B12"
    ],
    "Specimen Type(s)": [
        "Human serum matrix"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Elecsys\u00ae immunoassay systems"
    ],
    "Method(s)/Technology(ies)": [
        "Immunoassay"
    ],
    "Methodologies": [
        "Quality control"
    ],
    "Submission Type(s)": [
        "Control",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for Roche Elecsys\u00ae PreciControl Universal, a lyophilized multi-analyte quality control material for use on Elecsys immunoassay systems",
    "Indications for Use Summary": "Used for quality control of Elecsys\u00ae immunoassays on Elecsys\u00ae immunoassay systems",
    "fda_folder": "Clinical Chemistry"
}